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Abstract
Alzheimer’s disease (AD)-associated amyloid β peptide (Aβ) is one of the main actors in
AD pathogenesis. Aβ is characterized by its high tendency to self-associate, leading to
the generation of oligomers and amyloid fibrils. The elucidation of pathways and interme-
diates is crucial for the understanding of protein assembly mechanisms in general and in
conjunction with neurodegenerative diseases, e.g., for the identification of new therapeu-
tic targets. Our study focused on Aβ42 and its oligomeric assemblies in the lag phase of
amyloid formation, as studied by sedimentation velocity (SV) centrifugation. The assem-
bly state of Aβ during the lag phase, the time required by an Aβ solution to reach the expo-
nential growth phase of aggregation, was characterized by a dominant monomer fraction
below 1 S and a population of oligomeric species between 4 and 16 S. From the oligomer
population, two major species close to a 12-mer and an 18-mer with a globular shape
were identified. The recurrence of these two species at different initial concentrations and
experimental conditions as the smallest assemblies present in solution supports the exis-
tence of distinct, energetically favored assemblies in solution. The sizes of the two species
suggest an Aβ42 aggregation pathway that is based on a basic hexameric building block.
The study demonstrates the potential of SV analysis for the evaluation of protein aggrega-
tion pathways.
Introduction
Alzheimer's disease (AD) is an age-related disease with growing incidence in populations
with high life expectancies. As a consequence AD poses a major health risk to people and a
substantial worldwide economic burden [1]. Therefore, efforts to improve our understanding
of the disease mechanism have been taken to develop knowledge-based therapeutic concepts.
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It is well established that a proteolytic fragment of the amyloid precursor protein (APP)
plays a key role in disease pathogenesis, as reviewed in [2,3]. This 39 to 43 residue fragment
of the membrane spanning APP, referred to as the amyloid β peptide (Aβ), is highly prone to
self-association [4]. Although the monomeric form of Aβ is apparently nontoxic, the self-as-
sociated species exhibit neurotoxic behavior [5]. Fibrillar deposits of Aβ in intercellular pla-
ques are a histological marker for post-mortem AD diagnosis and are considered to be the
cause of neurodegeneration. More recently, however, it was found that soluble Aβ oligomers
are more neurotoxic than the amyloid fibrils and thus may represent the causative agents for
neurodegeneration [6–13]. Nevertheless, a conclusive, generally accepted definition of the
toxic oligomer is still missing [14]. As pointed out in [15] there are manifold challenges
for oligomer study, one of which is the rather low concentrations of the natural oligomeric
species in tissues and body fluids of AD patients, which hinder a direct preparation and char-
acterization. Additionally, it is difficult to control Aβ aggregation processes in vitro. There-
fore structural information that should aid the development of therapeutic interventions is
still missing.
Because there is obviously still need for clarification we engaged in this study in a thorough
characterization of Aβ aggregation by sedimentation velocity centrifugation (SV), one of the
major applications of analytical ultracentrifugation. SV analysis exhibits several advantageous
properties, making it especially attractive for the investigation of self-assembling proteins. SV
is a first-principles based method. No calibration standards are required as for instance neces-
sary in size exclusion chromatography to assign molecular weights to elution volumes. And
even more important the characterization is carried out in solution without a solid phase being
involved. In SV analysis all parameters regarding size distribution and shape of aggregates are
derived simultaneously from one specific Aβ solution. Although fractionation occurs due to
the sedimentation process, leading to improved detectability of the different species, aggregates
sediment always in the presence of equilibrium concentrations of smaller species and mono-
mers, preventing dissociation. Sedimentation velocity centrifugation (SV) is suitable for the
study of macromolecules ranging from a few thousand Da to several MDa. Measurement of
peptide concentrations by absorbance throughout the experiment guarantees control over pos-
sible losses of Aβ. In recent years, SV methodology has drastically improved in terms of infor-
mation content and resolution [16,17]. This is particularly pertinent in the field of aggregating
proteins where analytical ultracentrifugation has become an increasingly important technique
due to its unique properties [18–25]. In the case of self-assembling proteins, the samples consist
of mixtures of differently sized and shaped particles. In SV experiments the solute concentra-
tion as a function of the radial position within the rotor is recorded at regular time intervals.
These concentration profiles can be fitted by a sum of solutions of the Lamm equation [26].
The c(s) distribution [27] and genetic algorithm based analyses [28] are two implemented soft-
ware approaches to perform this data fitting task. In previously reported SV experiments, we
have demonstrated the power of the data evaluation method for the determination of size- and
shape-distributions of the Aβ peptide [29,30].
In our study we decided to investigate the early phase of Aβ42 self-assembly. We chose
Aβ42 because the elevation of its levels and of the ratio of Aβ42 to the shorter major form
Aβ40, had been identified as important early events in the pathogenesis of AD[31]. Specific
questions to be addressed are: what is the size of the smallest detectable oligomer in solution,
and do well-defined, oligomeric species exist as the hypothesis of a toxic oligomer might sug-
gest. For this purpose we restricted our analysis to the lag phase of aggregation as defined by
thioflavin T kinetic measurements.
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Materials and Methods
Amyloid β preparation
Synthetic human Aβ42 peptide was purchased as a trifluoroacetate salt (Bachem, Weil am
Rhein, Germany). For disintegration of preexisting aggregates, the peptide was predissolved in
100% hexafluoroisopropanol (HFIP) at 1 mg/mL and incubated overnight at room tempera-
ture. The solution was then divided into aliquots, lyophilized and stored at -8000B0030C until
required. Aβ42 was dissolved at pH 10 for analysis of a monomeric sample. To initiate aggrega-
tion the Aβ42 peptide was dissolved at concentrations from 10 to 240 μM in 10 mMNaPi buff-
er (6.2 mM sodium dihydrogen phosphate, 3.8 mM disodium hydrogen phosphate, pH 7.4).
Thioflavin T (ThT)-Assay
For the quantitative assessment of amyloid formation, freshly prepared Aβ42 samples in NaPi
buffer with 5 μMThT were incubated in a black 96-well fluorescence plate with an optical bot-
tom (Nunc, Thermo Scientific, Germany). ThT fluorescence was recorded every 30 min in a
plate reader (M1000, Tecan, Maennedorf, Switzerland) at λex = 446 nm and λem = 490 nm with
a bandwidth of 5 nm. The temperature was controlled at either 20 or 37°C.
CD spectroscopy
Circular dichroism spectroscopic measurements were carried out on a Jasco J-815 spectrome-
ter. A 1 mm optical path length cuvette was used. The temperature was controlled at 20°C. For
the measurement over time, sample incubation was not performed in the cuvette but in a stan-
dard sample tube, from which aliquots were taken. Spectra were recorded from λ = 260 nm to
185 nm at 1 nm resolution, 50 nm/min scan speed, and an integration time of 0.5 s. For signal
improvement ten accumulations were averaged. The obtained spectra were transformed from
ellipticity θ, measured in millidegrees (mdeg), to mean residue ellipticity (MRE) after subtrac-
tion of the buffer spectra.
Analytical Ultracentrifugation
Sedimentation velocity centrifugation experiments were carried out in a Beckman Optima
XL-A (Beckman-Coulter, Brea, CA, USA), equipped with absorption optics and a four-hole
rotor. Samples (volume 400 μL) were filled into standard aluminum or epon double sector cells
with quartz glass windows. Measurements were performed in the intensity mode [32] at detec-
tion wavelengths between 224 and 242 nm in order to adjust for different peptide concentra-
tions. For Aβ42 peptide concentrations above 40 μM the temperature was set to 10°C,
otherwise 20°C was chosen. Radial scans were recorded with 20 μm radial resolution at ~1.5
min intervals. The software packages UltraScan II v 9.9/III v 2.0 [28,33] and SEDFIT v 14.1[34]
were used for data evaluation. After transformation of the recorded sedimentation velocity
data, taken in the intensity mode, to either absorbance or pseudo-absorbance data in the re-
spective data evaluation software, time- as well as radially-invariant noise were calculated and
subtracted. In UltraScan a model-independent analysis approach for fitting SV data, which
permits simultaneous determination of shape and molecular weight distributions for mono-
and polydisperse solutions of macromolecules, was further refined by a parsimoniously regu-
larized fit of independent solutions of the Lamm equation applying a genetic algorithm (GA)
to ensure convergence into the global minimum [35]. The final results were subjected to a
Monte Carlo (MC) analysis with 50 iterations each. In SEDFIT, continuous sedimentation coeffi-
cient distributions c(s) were determined with 0.05 S resolution and an F-ratio = 0.95. Suitable
s-value ranges between 0 and 30 S and for GA f/f0 between 1 and 4 were chosen. Buffer density
AβOligomers Present in the Lag Phase
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and viscosity (Table 1) had been calculated with SEDNTERP v 20111201 beta [36,37]. The partial
specific volume of Aβ42 was calculated according to the method of Cohn and Edsall [38,39] as
implemented in SEDNTERP or UltraScan II/III (Table 1). Graphical output for SEDFIT results was
created with the software GUSSI vs 1.0.3, written by Chad A. Brautigam, University of Texas
Southwestern Medical Center. All reported s-values were corrected for 20°C and water and
therefore s20,w-values.
Results and Discussion
In this study we analyzed freshly prepared solutions of Aβ42 by analytical ultracentrifugation,
ThT-assay, and CD spectroscopy to gain insights into the early processes of Aβ42 self-assembly
within the lag phase of amyloid formation.
Monomer characterization at pH 10
In a first step, we wanted to characterize the hydrodynamic properties of monomeric Aβ42. At
basic pH Aβ42 is stable as a monomer [40]. In contrast to organic solvents like HFIP or TFE
[41] known for their monomer stabilizing properties the chosen basic conditions do not induce
an α-helical structure. At pH 10 (Fig 1) the Aβ42 peptide shows a secondary structure profile
comparable to the one determined at pH 7.4 for the earliest time point as shown in Fig 1. The
CD spectrum of the peptide at basic pH did not change within 2 d of incubation, indicating the
required stabilization of the peptide. To increase the certainty of species detection, we com-
pared two different software packages for analytical ultracentrifugation data evaluation, i.e.,
SEDFIT [34] and UltraScan [33].
The SV analysis of 20 μMAβ42 at pH 10 revealed that the Aβ42 solution consisted of 95%
monomers. In Fig 2 the calculated c(s) distribution shows a first peak at 0.6 ± 0.2 S, represent-
ing 94% of the sample, and a second broader peak at 4.8 ± 0.5 S, accounting for 6%. The signal
increase at s-values between 0 and 0.6 S indicated either the presence of smaller species than
Aβ42, i.e., fragments that we could neither identify in gel electrophoresis nor mass spectrome-
try or, more likely, a baseline deconvolution problem caused by the small size of the macromol-
ecules, preventing clearance of the meniscus region during centrifugation. The 0.6 S species fits
well to monomeric Aβ42, the 4.8 S species indicates an oligomer of 50 to 70 kDa. The weight
averaged f/f0 was fitted as 1.56. According Eq. 1 the 0.6 S species with f/f0 = 1.56 had a molecu-
lar weight of 4.4 kDa, which is close to the molecular weight of the monomeric Aβ42 (4.5 kDa).
In contrast to the c(s) determined s-value distribution (Fig 2) the GA-MC analysis in UltraScan
(Fig 3) fitted three species with an s-value smaller than 1, which differed significantly with re-
spect to their frictional ratios. The main species with 0.67 S had a smaller f/f0 value of 1.35 than
the main component from the c(s) analysis. Again the resulting molecular weight is close to 4.6
kDa, which confirmed the monomeric nature of the species. Taken together around 6% of the
aggregates with an average s-value of 5 S were detected independent from the data evaluation
procedure. These aggregates might comprise either residually undissolved material or newly
formed assemblies.
Table 1. Solvent parameters for 10 mMNaPi, pH 7.4 andv of Aβ42 for the temperatures used in the
SV experiments. Calculations were performed with SEDNTERP or UltraScan II/III.
temperature (°C) v (cm3/g) density (g/cm3) viscosity (cp)
10 0.734 1.0011 1.3109
20 0.738 0.9996 1.0048
doi:10.1371/journal.pone.0127865.t001
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Fig 1. CD-spectroscopy of Aβ42 at pH 10.CD spectra measured at the start of the incubation (black) and
after 48 h (grey) at 20°C. Spectra are in agreement with a random coil dominated secondary structure with a
characteristic minimum around 200 nm.
doi:10.1371/journal.pone.0127865.g001
Fig 2. SV-analysis of Aβ42 at pH 10. 40 μMAβ42 had been centrifuged at 40,000 rpm and 20°C. By c(s)
analysis the most prominent species was detected at s = 0.6 S (A); GA-MC analysis revealed the dominant
species at s = 0.67S with f/f0 = 1.35 (B). Results are presented in a pseudo-3D plot with a color coded third
dimension indicating the species fraction. In both evaluations a small amount of near spherical aggregates
appeared at 5 S. The minor species detected below 1 S are artifacts due to a base line
deconvolution problem.
doi:10.1371/journal.pone.0127865.g002
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The experimentally determined s-value of the monomer is in agreement with an s-value of
0.55 S reported in the literature [42]. In the PDB a high resolution structure of full-length Aβ42
exists, that was determined by NMR in an HFIP-water mixture (1Z0Q) [43]. The s-value calcu-
lated for a bead model [44,45] built from this NMR structure of Aβ42, is 0.72 S and the frictional
ratio is 1.3. The structure is characterized by 42% helices and several turns giving it a more com-
pact conformation. In comparison we can conclude that the Aβ42 monomer at pH 10 character-
ized in our experiments had a more elongated shape, i.e., it was less structured than the structure
deposited in the PDB. This result is in agreement with the peptide adopting a random-coil domi-
nated structure, when the helix inducing agent HFIP is not present in the sample buffer.
Length of the lag phase
An SV experiment for Aβ42 monomers at 20°C and 60,000 rpm corresponding to 257,000 g
takes 6 to 10 h, because of the slow sedimentation of the monomer. If assemblies present in the
lag phase are to be characterized, the lag phase has to last longer than the experimental analysis.
Entry into the rapid growth phase would also cause profound changes to the sample composi-
tion, thereby complicating data analysis. To determine the length of the lag phase, we followed
the process of amyloid formation starting from freshly dissolved Aβ42 by a ThT fluorescence
assay (Fig 3A). Measurement over time typically results in a sigmoidal curve, that is subdivided
into the lag phase during the initial stage, a steep increase in fluorescence during the growth
phase, that represents the formation of amyloid fibrils, and finally the plateau region, where
fluorescence is constant and then decreases slightly after a period due to precipitation. The du-
ration of the lag phase was about 80 h for 40 μMAβ42 (Fig 3A) at 20°C. To complement the
fluorescence data, the structural conversion from random coil to β-sheet structure, which ac-
companies self-assembly of monomeric Aβ42 units to fibrils with an amyloid specific cross-β
conformation, was monitored by CD spectroscopy. In Fig 3B, CD spectroscopic measurements
over time at 20°C for a 37 μMAβ42 solution indicated a conformational change, characterized
by the presence of an isosbestic point, within 49 to 74 h. The isosbestic point at 209 nm sug-
gests a two-state transition between random coil and β-sheet conformation. The duration of
the lag phase determined by the CD measurements and the ThT assay were within the same
order of magnitude. Shortening of the lag phase with increasing initial Aβ42 concentrations
Fig 3. Kinetics of amyloid formation. ThT-fluorescence kinetics of 40 μMAβ42 in 10 mMNaPi at 37°C (black) and 20°C (blue). The maximumRFUs had
been normalized to 1. Determined lag times were ~8 h at 37°C and ~80 h at 20°C (A). CD spectra of 37 μMAβ42 incubated at 20°C for 0 (black), 29
(magenta), 49 (cyan) and 74 h (blue). The spectrum of Aβ42 in NaPi, pH 7.4 changes within the indicated times from a predominantly random coil spectrum to
a β-sheet rich spectrum. Superimposed spectra possess an isosbestic point at 209 nm, indicating a two-state transition (B).
doi:10.1371/journal.pone.0127865.g003
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was compensated by reducing the temperature from 20 to 10°C during SV analysis of samples
at concentrations higher than 40 μM. It was therefore possible to perform the SV experiments
within the lag phase of the system and before the initiation of the rapid growth phase.
Concentration dependent self-association
Samples were prepared by freshly dissolving HFIP pretreated synthetic Aβ42 at different initial
concentrations. At the start of the sedimentation process all samples had a history of ~1 h han-
dling and thermal equilibration time. Calculation of the initial peptide concentration from a
first scan at 3000 rpm and the first scan at 55,000 and 60,000 rpm, respectively, revealed a defi-
cit between 20 and 25% for all samples. Material might have been lost to inter-/surfaces, undis-
solved, and/or sedimented during the acceleration phase. In a first approach, the SV data were
evaluated in a model independent manner by the van Holde-Weischet (vHW) method [46].
Fig 4 shows the combined vHW-distribution plots for 40, 80, 160, 200 and 280 μM initial Aβ42
concentrations. Analyzed solutions showed bimodal distributions characterized by a slowly
sedimenting, rather homogenous fraction, visible at the near vertical line in the vHW-distribu-
tion at small s-values, and a clearly separated, faster sedimenting fraction with s-values ranging
between 4 and 15 S. The Aβ42 species detected at s-values below 1 S were assigned to mono-
meric species based on the monomer characterization at pH 10 (Fig 2). The proportion of olig-
omeric species was found to increase from ~30% to ~50% without populating oligomeric
species larger than 20 S by a sevenfold increase of the initial Aβ42 concentration of 40 μM.
Under the applied experimental conditions, that is speed, temperature, and solvent, molecular
species up to 200 S would be detectable in SV analysis. As a consequence the weight averaged s-
Fig 4. G(s) distributions for different initial concentrations of Aβ42.Model independent analysis of SV
data by the van Holde-Weischet method for freshly prepared Aβ42 solutions with 40 μM (cyan triangle),
80 μM (magenta diamond), 160 μM (yellow circle), 200 μM (blue triangle upwards), and 280 μM (red triangle
leftwards) initial monomer concentrations.
doi:10.1371/journal.pone.0127865.g004
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value of the oligomer fraction increased with increasing Aβ42 concentration. The near hori-
zontal curve progression between s-values 1 and 4 S indicates the absence of detectable Aβ42
assemblies in this area and marks therefore the range where kinetically unstable intermediates
might be located. Sedimenting species with s-values between 1 and 4 S would correspond to
oligomers ranging from dimer to octamer assuming a spherical shape, thus giving lower size
limits of the intermediates. A further observation was a slight shift of the monomer peak to
smaller s-values for those measurements performed at 10°C when compared with the data re-
corded for a 40 μMAβ42 sample at 20°C. The observed change in s-value could be the result of
a temperature induced conformational change leading to an altered frictional coefficient of the
monomer in solution. Alternatively or additionally the shift might be due to the presence of an
unresolved fast equilibrium, e.g. between the monomer and a dimer.
Our major objective was to identify discrete Aβ42 oligomeric species. Such species should
feature energetically favored assemblies consisting of a well-defined number of monomeric
units. To identify single species, the data were evaluated by calculating c(s) distributions, as
well as by applying a parsimoniously regulated genetic algorithm, as implemented in Ultra-
Scan. For both approaches the underlying models assume the existence of a number of inde-
pendent species in solution. For a rapid equilibrium with the smaller compound being present
in excess as is the case in our system c(s) is a valid approximation for data evaluation [47]. Pro-
vided that seed formation in the lag phase is a slow and rare process, the solution state could be
approximated as steady-state equilibrium. This assumption was corroborated by small root
mean square deviation (rmsd) values obtained by measuring the agreement between measured
and calculated data, which amounted to ~0.5% of the total signal. In Fig 5 the noise subtracted
raw data together with the fitted curves of SV runs with three different initial Aβ42 concentra-
tions (A, B and C) and the combination of the resulting c(s) distributions (D) are shown.
As part of the oligomer fraction two prominent species were repeatedly detected by c(s)
analysis (Fig 5D) with s-values averaged for 9 independent samples of 4.70 S ± 0.27 S and 6.25
S ± 0.28 S (Table 2). These two species were observed under different experimental conditions,
i.e., initial Aβ42 concentration, rotor speed and temperature. A third species appeared as a
shoulder of the larger species with an s-value of 6.2 to 7.6 S. The smaller species at 2.6 S, and
any species larger than 10 S were detected at too low concentrations to be reliably assigned. In c
(s) a global f/f0 weight averaged for all s-value species was determined. As already noticeable in
the vHW-distribution (Fig 4) the percentage of oligomeric species in the range between 1 and
15 S increased with increasing initial Aβ42 concentrations, while concomitantly weight aver-
aged f/f0 decreased from 1.6 to 1.2 (data not shown). This indicates an increase of globular par-
ticles present in solution. To resolve individual shape parameters data evaluation was
performed by applying GA in UltraScan. The monomeric species showed a slightly extended
conformation with an f/f0 of 1.6, in agreement with the results from SV analysis at pH 10 (Fig
2). For the oligomers ranging from 4 to 10 S, f/f0 values< 1.3 were calculated, which is consis-
tent with the results from c(s) showing less extended conformations with increasing fractions
of oligomeric species. Although the determined s-values for the two species could be repro-
duced by the GA algorithm (Fig 6), the Monte Carlo statistics for the GA results revealed con-
siderable uncertainties for f/f0 determinations, probably due to the comparatively low number
of scans reporting about the sedimentation and diffusion properties of the larger species. Al-
though no conclusive f/f0 values for single species could be retrieved, both methods support a
globular shape of the oligomers. The obtained shape information had been confirmed by AFM
measurements (data not shown). Additionally it is in agreement with reported AFM and TEM
studies from literature [48,49].
Calculations of the molecular weights of the oligomers based on the determined s-values uti-
lizing shape factors (f/f0) between 1.0 and 1.1, typical for globular proteins, using the following
AβOligomers Present in the Lag Phase
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Table 2. Observed s-value species of Aβ42. The oligomeric state was determined for a globular particle
with f/f0 = 1.1. The error was calculated as standard deviation of the mean of s-values obtained by applying
the c(s) routine to the given number of different data sets. Different data sets correspond to independent
sample preparations.
s-value [10–13 s] ± SD Number of data sets
Monomer 0.62 ± 0.02 12
12-mer 4.70 ± 0.27 9
18-mer 6.25 ± 0.28 9
doi:10.1371/journal.pone.0127865.t002
Fig 5. SV analysis of Aβ42 at different initial concentrations. The noise corrected data (dots) superimposed with fitted curves (lines) from c(s) analysis,
and the residuals plot attached below, are shown for 40 μM (A), 80 μM (B), and 160 μM (C) initial concentrations of Aβ42. For clarity, only every second scan
and every third data point is shown. The combined c(s) distributions for 40 μM (cyan) measured at 20°C, 80 μM (magenta) measured at 10°C, and 160 μM
(blue) measured at 10°C are shown in (D). The monomer peak below 1 S has been excluded from the plot.
doi:10.1371/journal.pone.0127865.g005
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equation
s020;w ¼
1 vrð Þ
f =f0  6Zð Þ

ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
4
3v
M  n
p  NA
 2
3
s
with solvent density (ρ) and viscosity (η) revealed for the 4.7 S species a size corresponding to
11 to 13 Aβ42 monomeric units (n M,Mmolecular weight of Aβ42) and for the 6.25 S species
accordingly 17 to 20 monomeric Aβ42 units. The third species in the range of 6.2 to 7.6 S cov-
ers oligomeric species built from 22 to 29 monomeric units.
The determined sizes further supports prior evidence of a hexameric building block in Aβ42
aggregation [50–52] A hypothetical Aβ42 hexamer with an s-value between 1.9 (f/f0 = 1.6) and
3.1 S (f/f0 = 1.0) would be located within the predetermined gap between 1 and 4 S. The hexamer
is not detected in solution because it is a kinetically unstable intermediate. The fraction of oligo-
meric species in solution is concentration dependent and reached 75% at 280 μMAβ42 initial
concentration; taking the 25% loss of Aβ42 during acceleration into account the fraction is 56%.
Although the described oligomers were detected free in solution for the first time, their sizes
agree well with previously reported species. A dodecamer was detected by PICUP [6,52] and
confirmed by ion mobility spectrometry-mass spectrometry [53]. Dodecameric assemblies
were also described as Aβ-derived diffusible ligands and a specific assembly detected in cere-
brospinal fluid, Aβ56. Additionally, the oligomeric species termed globulomer [54] is a dode-
camer, although the preparation of this species required SDS for maintaining stabilization.
Experimental and theoretical evidence fromMD simulations exists for the 18mer [55–57]. In
contrast to our work, the 18mer reported in these references is dependent on hydrophobic in-
teractions either with lipids in a bilayer or fatty acids. Kumar et al. [56] showed c(s) distribu-
tions for their large fatty acid-derived Aβ oligomers with peaks at 5 and 7 S, which are similar
to our c(s) distributions obtained for Aβ42.
In our study of Aβ42, oligomerization clearly preceded the conversion to a β-sheet conforma-
tion. This is in contrast to an analytical ultracentrifugation based study of the prion protein (PrP),
where the detected small oligomers showed significantly larger shape factors f/f0 than the PrP
monomer, and oligomerization happened in the same time frame as the structural conversion to
a β-sheet dominated structure as demonstrated by CDmeasurements [24]. The 12-mer and the
Fig 6. Pseudo-3D plot of Aβ42 size and shape distribution. Results from a SV analysis of 280 μMAβ42 at
60,000 rpm and 10°C. Data were evaluated by 2-dimensional spectrum analysis followed by GA-MC analysis.
doi:10.1371/journal.pone.0127865.g006
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18-mer were detected reproducibly under different speed conditions, temperature and initial
Aβ42 concentrations. With increasing initial Aβ42 concentrations the fraction of these oligomers
increased rather than larger aggregates forming. This is the first time that these species were de-
tected free in solution. We suggest that these species are part of an oligomer formation pathway
similar to the one proposed by Barghorn et al. [54] based on hexameric building blocks; although
we believe that the two pathways for either fibril or oligomer formation are not completely sepa-
rated from each other. To resolve this question, the addition of oligomers to monomeric Aβ solu-
tions must be tested to determine whether a decrease in the lag phase is observed. Additionally, it
should be clarified whether the observed oligomers are cytotoxic towards neuronal cells. There-
fore, oligomers have to be purified away frommonomers and larger assemblies.
Conclusions
The pathogenic aggregation mechanism of the amyloid beta peptide is still a matter of debate. Es-
pecially the nature of a postulated oligomer responsible for the neurodegeneration in Alzheimer's
disease is elusive. In this study we utilized a technique that allows for observation of all species
present within a sample at a given time point without complications arising from involvement of
solid phases or necessity for any calibration. Size, shape, and quantity of all observed s-value spe-
cies could be determined simultaneously, avoiding unaccounted changes in sample composition
in the course of multi-step analysis procedures. In contrast to our expectations it was possible to
increase the initial Aβ42 concentration above 1 mg/ml without generating larger aggregates and
fibrils within the experimental time frame. This was caused or at least supported by the reduced
temperature of 10°C and the property of the SVmethod to deplete solutions of larger aggregates,
which might act as seeds for amyloid formation. Such particles with high s-values are removed by
their rapid sedimentation during the early phases of centrifugation, i.e., by their rapid sedimenta-
tion already during the acceleration phase. We were able to demonstrate the existence of distinct
oligomeric species in solutions of Aβ42 during the lag phase of amyloid formation. These oligo-
mers appeared to be globular in shape, while the monomer showed a slightly extended conforma-
tion. During the experiment, starting from a homogeneously filled cell, the characterized
oligomers sedimented always in the presence of smaller species, thus maintaining equilibrium be-
tween distinct oligomeric species and smaller oligomers and monomers. The postulated equilibri-
um is in agreement with the observation that increasing the initial Aβ42 concentration led rather
to an increase of the oligomer fraction than to the appearance of aggregates above 20 S.
The two recurring species were interpreted as an 11 to 13mer for the smaller and a 17 to
20mer for the larger oligomer assuming a frictional ratio between 1.0 and 1.1. The numbers are
tempting to suggest a model based on a hexameric building block as recently proposed in [58].
The high reproducibility of the s-values as well as their independence from the initial Aβ42
concentration clearly indicates the existence of energetically favored assemblies among possible
oligomeric states. It can be assumed that the defined size of the oligomers correlates with an
equally well defined secondary and tertiary structure. Such characterized species would be ideal
candidates for specific, pathogenic interactions with cellular receptors or other interaction
partners. Whether the observed oligomers are on or off-pathway to the amyloid fibrils cannot
be concluded, although it seems probable that once a certain number of monomeric units are
assembled this might be the place where—triggered by a conformational rearrangement—the
rapid growth of fibrillar structures initiates.
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